Showing results (101-110 of 122) with videos related to
Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 1998
Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587)C A Dionne, A M Camoratto, J P Jani, et al.Brain Research|July 9, 1990
Inhibition of potassium-evoked release of cholecystokinin from rat caudate-putamen, cerebral cortex and hippocampus incubated in vitro by phencyclidine and related compoundsL R Allard, J S Brog, J C Viereck, et al.The Journal of Comparative Neurology|August 26, 1998
Immunolocalization of the mitogen-activated protein kinases p42MAPK and JNK1, and their regulatory kinases MEK1 and MEK4, in adult rat central nervous systemD G Flood, J P Finn, K M Walton, et al.Synapse (New York, N.Y.)|January 1, 1987
PCP-induced alterations in cerebral glucose utilization in rat brain: blockade by metaphit, a PCP-receptor-acylating agentC A Tamminga, K Tanimoto, S Kuo, et al.Neuropharmacology|December 1, 1990
Opipramol, a potent sigma ligand, is an anti-ischemic agent: neurochemical evidence for an interaction with the N-methyl-D-aspartate receptor complex in vivo by cerebellar cGMP measurementsT S Rao, J A Cler, S J Mick, et al.Peptides|September 1, 1984
Evidence for an endogenous peptide ligand for the phencyclidine receptorR Quirion, D A DiMaggio, E D French, et al.Journal of Neurochemistry|March 1, 1991
Contrasting neurochemical interactions of tiletamine, a potent phencyclidine (PCP) receptor ligand, with the N-methyl-D-aspartate-coupled and -uncoupled PCP recognition sitesT S Rao, P C Contreras, J A Cler, et al.Journal of Neurochemistry|March 11, 1991
Neurochemical interactions of competitive N-methyl-D-aspartate antagonists with dopaminergic neurotransmission and the cerebellar cyclic GMP system: functional evidence for a phasic glutamatergic control of the nigrostriatal dopaminergic pathwayT S Rao, J A Cler, S J Mick, et al.Neuropharmacology|August 1, 1991
(+) 3-[3-hydroxyphenyl-N-(1-propyl) piperidine] selectively differentiates effects of sigma ligands on neurochemical pathways modulated by sigma receptors: evidence for subtypes, in vivoS Iyengar, P L Wood, S J Mick, et al.The Journal of Biological Chemistry|April 28, 2001
Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase familyA C Maroney, J P Finn, T J Connors, et al.Pageof 13